DECIBEL THERAPEUTICS INC's ticker is DBTX and the CUSIP is 24343R106. A total of 1 filers reported holding DECIBEL THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $73,500 | +27.5% | 19,091 | 0.0% | 0.00% | – |
Q1 2023 | $57,655 | +65.0% | 19,091 | +12.0% | 0.00% | – |
Q4 2022 | $34,938 | -43.6% | 17,043 | -5.5% | 0.00% | – |
Q3 2022 | $62,000 | +3.3% | 18,043 | +26.7% | 0.00% | – |
Q2 2022 | $60,000 | +39.5% | 14,239 | 0.0% | 0.00% | – |
Q1 2022 | $43,000 | -35.8% | 14,239 | 0.0% | 0.00% | – |
Q4 2021 | $67,000 | -42.7% | 14,239 | -6.6% | 0.00% | – |
Q3 2021 | $117,000 | -10.7% | 15,239 | 0.0% | 0.00% | – |
Q2 2021 | $131,000 | -85.1% | 15,239 | -80.3% | 0.00% | – |
Q1 2021 | $879,000 | – | 77,392 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP III, LLC | 3,139,685 | $14,600,000 | 3.65% |
Samsara BioCapital, LLC | 826,422 | $3,843,000 | 0.75% |
Orbimed Advisors | 4,945,192 | $22,995,000 | 0.30% |
Alphabet Inc. | 1,636,258 | $7,609,000 | 0.18% |
Casdin Capital, LLC | 1,170,048 | $5,441,000 | 0.15% |
HARVARD MANAGEMENT CO INC | 328,798 | $1,529,000 | 0.14% |
Bronte Capital Management Pty Ltd. | 157,216 | $731,000 | 0.05% |
ATLAS CAPITAL ADVISORS LLC | 41,025 | $190,766,000 | 0.03% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 263,600 | $1,226,000 | 0.02% |
Woodline Partners LP | 275,001 | $1,279,000 | 0.02% |